nedaplatin has been researched along with Adenocarcinoma, Clear Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Li, H; Li, K; Li, X; Liu, Y; Lou, G; Yin, M; Zhang, H | 1 |
| Ichikawa, Y; Nishida, M; Tsunoda, H; Yoshikawa, H | 1 |
| Kubo, T; Nishida, M; Nishide, K; Satoh, Y; Tsunoda, H | 1 |
1 trial(s) available for nedaplatin and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
[Phase I study of a combination chemotherapy of nedaplatin and cisplatin].
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms | 1999 |
2 other study(ies) available for nedaplatin and Adenocarcinoma, Clear Cell
| Article | Year |
|---|---|
The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma.
Topics: Adenocarcinoma, Clear Cell; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Humans; Irinotecan; Middle Aged; Organoplatinum Compounds; Ovarian Neoplasms; Parity; Treatment Outcome | 2004 |